KCM
HCAT icon

Kingdon Capital Management’s Health Catalyst HCAT Stock Holding History

Kingdon Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-521,000
Closed -$6.51M – 90
2023
Q2 		$6.51M Buy
+521,000
New +$6.2M 0.62% 47

Other funds holding HCAT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DG
Daventry Group New York $133M AUM 32.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kingdon Capital Management's HCAT Position: Q3 2023 in Review

Kingdon Capital Management sold out of Health Catalyst (HCAT) in Q3 2023, closing a stake of 521,000 shares — an estimated $6.51M sold.

Kingdon Capital Management first reported a position in HCAT in Q2 2023 and held it in 1 quarter. The position peaked at $6.51M in Q2 2023. 159 funds tracked by Wall St. Rank hold HCAT as of Q3 2023.

  • Kingdon Capital Management reported no remaining Health Catalyst position as of Q3 2023 after selling out during the quarter.
  • Kingdon Capital Management sold 521,000 Health Catalyst shares in Q3 2023, an estimated $6.51M.
  • Kingdon Capital Management first reported a position in Health Catalyst in Q2 2023 and held it in 1 quarter.
  • Kingdon Capital Management's Health Catalyst position peaked at $6.51M in Q2 2023.
  • 159 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2023.

Based on Kingdon Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.